Old Web
English
Sign In
Acemap
>
Paper
>
Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab.
Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab.
2021
Maria Cristina Puzzolo
Giulia Radice
Nadia Peragine
Maria Stefania De Propris
Paola Mariglia
Marco Vignetti
Antonella Vitale
Renato Bassan
Mario Annunziata
Gianluca Gaidano
Alessandro Rambaldi
Sabina Chiaretti
Anna Guarini
Robin Foà
Keywords:
Blinatumomab
Ph+ acute lymphoblastic leukemia
Dasatinib
Immune system
Cancer research
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
26
References
0
Citations
NaN
KQI
[]